Drug Discovery 2022: driving the next life science revolution

Mr Tom Fleming

Mr Tom Fleming
Mr Tom Fleming
Co-Founder & COO
Arctoris
Delegate / Speaker

Presentations at Drug Discovery 2022: driving the next life science revolution

Profile of Mr Tom Fleming

Thomas A. Fleming MChem FRSA FRSB FRSC, Co-Founder & COO of Arctoris, is an organic chemist by background with research experience in early-stage drug discovery, chemical biology, cheminformatics and laboratory automation. Thomas is a Fellow of the Royal Societies of Biology, Chemistry, and Arts. He was previously an Industrial Fellow with the Royal Commission for the Exhibition of 1851 and scholar at the University of Oxford, and an SME Leadership Fellow at the Royal Academy of Engineering. Thomas is an ELRIG Impact Award winner, and is cited in the Top 100 Most Influential People in Healthcare and Lifesciences.

Colleagues

Dr Martin-Immanuel Bittner
CEO
Arctoris
Dr John Evans
Principal Scientist
Arctoris
Dr Daniel Thomas
Head of Discovery Biology
Arctoris
Ms Yaoyao Xiong
Scientist
Arctoris

Email

Please login to send a Private Message

Hosted By

ELRIG

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'